CIK 0001776111 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
MBX Biosciences, Inc.
Sign in to watch- Ticker
- MBX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 3179893100
- Business address
- 11711 N. MERIDIAN STREET, SUITE 300, CARMEL, IN, 46032
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $288,361
- in 2 filings
Net −$288,361. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-10-24 | Hawryluk P. Kent President & CEO | Option exercise · Stock option (right to buy) | −182,859 | 129,708 | ||
| 2025-10-20 | Hawryluk P. Kent President & CEO | Purchase | +20,000 | $13.64 | $273K | 468,277 |
| 2025-10-17 | Hoerter Steven L. Director | Purchase | +20,000 | $13.25 | $265K | 20,000 |
| 2025-09-26 | Heron Patrick J Director | Purchase | +666,666 | $18.00 | $12.0M | 5,219,440 |
| 2025-06-05 | Mathers Edward T Director | Grant or award · Stock option (right to buy) | +16,000 | 16,000 | ||
| 2025-06-05 | Hoerter Steven L. Director | Grant or award · Stock option (right to buy) | +16,000 | 16,000 | ||
| 2025-06-05 | Aynechi Tiba Director | Grant or award · Stock option (right to buy) | +16,000 | 16,000 | ||
| 2025-06-05 | CORNELIUS JAMES M Director | Grant or award · Stock option (right to buy) | +16,000 | 16,000 | ||
| 2025-06-05 | Ryder Steven Director | Grant or award · Stock option (right to buy) | +16,000 | 16,000 | ||
| 2025-06-05 | Heron Patrick J Director | Grant or award · Stock option (right to buy) | +16,000 | 16,000 | ||
| 2025-06-05 | Pescovitz Ora H. Director | Grant or award · Stock option (right to buy) | +16,000 | 16,000 | ||
| 2025-04-08 | Pescovitz Ora H. Director | Purchase | +7,693 | $5.89 | $45K | 24,329 |
| 2025-04-07 | Hoerter Steven L. Director | Grant or award · Stock option (right to buy) | +32,000 | 32,000 | ||
| 2025-02-18 | GORDON CARL L Director | Purchase | +49,070 | $10.84 | $532K | 3,255,000 |
| 2025-02-18 | GORDON CARL L Director | Purchase | +94,100 | $10.84 | $1.0M | 747,887 |
| 2025-02-18 | ORBIMED ADVISORS LLC Director | Purchase | +49,070 | $10.84 | $532K | 3,255,000 |
| 2025-02-18 | ORBIMED ADVISORS LLC Director | Purchase | +94,100 | $10.84 | $1.0M | 747,887 |
| 2025-02-14 | GORDON CARL L Director | Purchase | +17,962 | $9.90 | $178K | 3,176,390 |
| 2025-02-14 | GORDON CARL L Director | Purchase | +29,540 | $9.85 | $291K | 3,205,930 |
| 2025-02-14 | ORBIMED ADVISORS LLC Director | Purchase | +17,962 | $9.90 | $178K | 3,176,390 |
Page 3 of 9 · 164 trades